| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3283633 | Clinical Gastroenterology and Hepatology | 2012 | 8 Pages |
Abstract
The results of this systematic review suggest that the majority of patients with GERD are relatively adherent to their PPI, although substantially different estimates were obtained using MPR data compared with surveys. Severe symptoms and the presence of Barrett's esophagus may increase PPI adherence, and other GERD medication is frequently taken in addition to a PPI. Limitations of studies in this area include inferring adherence from indirect MPR data, and recall bias associated with patient surveys.
Keywords
PPIPCPOTCprimary care practitionerICD-9-CMH2RAMPRICD-9GERDHistamine-2 receptor antagonistover-the-countergastroesophageal reflux diseaseAdherenceRelative riskConcomitant medicationinternational classification of diseases, ninth revision, clinical modificationInternational Classification of Diseases, Ninth Revisionconfidence intervalDosing frequencyBarrett's esophagusProton pump inhibitorMedication possession ratioodds ratio
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
A. Pali S. Hungin, Catherine Hill, Michael Molloy-Bland, Anan Raghunath,